Treatment of V1 Herpes Zoster

First-Line Treatment Options

The American Academy of Dermatology recommends valacyclovir 1 gram orally three times daily for 7 days as the preferred treatment for uncomplicated V1 herpes zoster due to its superior bioavailability and convenient dosing schedule 1
Alternative first-line options include famciclovir 250 mg orally three times daily for 7 days, which has demonstrated similar efficacy to valacyclovir 1

For severe cases or immunocompromised patients, the Infectious Diseases Society of America recommends intravenous acyclovir 5-10 mg/kg every 8 hours 1, 2
Treatment should continue until clinical improvement occurs, then switch to oral therapy to complete the course, as recommended by the American College of Physicians 1
Temporary reduction in immunosuppressive medication is recommended if applicable, according to the American Academy of Dermatology 1

The American Academy of Ophthalmology recommends careful monitoring for ocular involvement in patients with V1 (ophthalmic) distribution 2
If ocular involvement is present, consider ophthalmology consultation, as advised by the American College of Physicians 1

The Infectious Diseases Society of America states that immunocompromised patients are at higher risk for dissemination and complications 2
Intravenous acyclovir is recommended for immunocompromised patients with V1 herpes zoster, according to the American College of Physicians 1, 2
Lesions may continue to develop over a longer period (7-14 days) and generally heal more slowly in immunocompromised hosts, as noted by the Infectious Diseases Society of America 2
Monitor closely for dissemination and secondary bacterial or fungal superinfections, as recommended by the American Academy of Dermatology 2

The American College of Physicians recommends that oral therapy should be reserved for mild cases in immunocompromised patients; more severe cases require intravenous acyclovir 2